Yes, genetic testing can be instrumental in Neurocare. It can help identify individuals at high risk for certain conditions, enabling early intervention and personalized treatment plans. For instance, the presence of specific genetic markers can indicate a higher risk for developing multiple sclerosis, allowing for proactive monitoring and management.
